Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Segment Reporting Financial Information (Details)

v3.22.4
Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]    
Revenues $ 101,911,409 $ 80,859,653
Depreciation and amortization 7,643,980 6,088,947
Segment operating income 2,076,861 5,352,419
Other expense, net (133,101) (69,878)
Income before income tax expense (benefit) 1,943,760 5,282,541
Segment operating income:    
Segment Reporting Information [Line Items]    
Segment operating income 2,076,861 5,352,419
Unallocated corporate    
Segment Reporting Information [Line Items]    
Segment operating income (16,622,405) (15,787,096)
Corporate clinics    
Segment Reporting Information [Line Items]    
Revenues 59,422,294 44,348,234
Depreciation and amortization 6,554,852 5,446,663
Corporate clinics | Segment operating income:    
Segment Reporting Information [Line Items]    
Segment operating income (887,101) 4,432,872
Franchise operations    
Segment Reporting Information [Line Items]    
Revenues 42,489,115 36,511,419
Depreciation and amortization 744,172 334,945
Franchise operations | Segment operating income:    
Segment Reporting Information [Line Items]    
Segment operating income 19,586,367 16,706,643
Corporate administration    
Segment Reporting Information [Line Items]    
Depreciation and amortization $ 344,956 $ 307,339